Suraksha Diagnostic Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹420 - ₹441
- Lot size
- 34 shares
- Issue amount
- ₹846.25 cr
- Total subscription
- 1.27×
- Opens
- 29 Nov 2024
- Closes
- 3 Dec 2024
- Allotment
- 4 Dec 2024
- Listing
- 6 Dec 2024
Offer at a glance
Issue overview
- Issue size
- 1,91,89,330 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹14,280
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹846.25 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,994
- Issue type
- Bookbuilding IPO
- Shares before issue
- 5,20,80,758
- Shares after issue
- 0
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 1 | 34 | ₹14,994 |
| sHNI | 14 | 476 | ₹2,09,916 |
| bHNI | 67 | 2,278 | ₹10,04,598 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 0 | 1,86,845 |
| HNIs(10L +) | 0 | 6,155 |
| HNIs (2-10L) | 0 | 2,343 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 0 | 294.03 |
| RETAIL | 296.19 | 280.16 |
| HNIs 2+ | 42.31 | 49.18 |
| HNIs 10+ | 84.62 | 129.21 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Jun-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 1.49 | 4.43 | 1.22 |
| ROE | 4.33 | 14.09 | 4.32 |
| ROCE | 6.32 | 21.46 | 9.05 |
| RONW | 4.33 | 14.09 | 4.32 |
| Pre IPO | 99.31 | 0 | 0 |
| Post IPO | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Suraksha Diagnostic Limited, incorporated on March 15, 2005, is a technology-driven diagnostic chain offering integrated pathology, radiology, and medical consultancy services. The company provides over 2,300 tests across multiple specialties through a network that includes a central reference laboratory, 8 satellite laboratories, and 194 customer touchpoints, comprising 48 diagnostic centers and 146 sample collection centers. Additionally, 43 diagnostic centers house 120 polyclinics staffed by over 750 doctors, providing online and offline consultations. Leveraging advanced technology such as LIMS, RIS, PACS, and ERP systems, Suraksha Diagnostic enhances operational efficiency and reduces turnaround times. The company also offers vaccination services, customized testing packages for early disease detection, and AI-driven digital pathology solutions, with all radiology reports digitally processed to enable seamless reporting across centers.
Strengths
- Strong Market Position: Leading diagnostics chain in eastern and northeastern India with growth potential in a fragmented market.
- Comprehensive Offerings: Integrated pathology, radiology, and medical consultancy services with a wide network of diagnostic and sample collection centers.
- Technological Edge: Advanced clinical infrastructure with digital pathology, AI-driven diagnostics, and efficient systems including LIMS, RIS, PACS, and ERP.
Risk factors
- Geographic Concentration: Heavy reliance on West Bengal for 95.48% of revenue makes the company vulnerable to regional disruptions affecting operations and financial performance.
- Promoter Group Issues: Past suspension of securities of certain Promoter Group members raises reputational concerns and may complicate future capital raising.
- Intense Competition: Operating in a competitive diagnostics industry with a modest market share (1.15–1.30% in East India) could restrict growth and profitability.
Promoters
Dr. Somnath Chatterjee
Ritu Mittal
Satish Kumar Verma
Registrar & documents
Lead manager
ICICI Securities Limited, Nuvama Wealth Management Limited, SBI Capital Markets Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat, Kolkata 700 156, West Bengal, India
+91 33 66059750
[email protected]Understanding SURAKSHA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.